SCHEMBL4353840

SCHEMBL4353840

Cc1cc(C)c(S(=O)(=O)OC2CCCCC2)cc1S(=O)(=O)OC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
PKM P14618 1/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 2/20 0.35
CYP2D6 P10635 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
F2 P00734 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395451 0.82 CYP2D6 (0.42) HTTCA1CA2LMNAGAA
SCHEMBL27415716 0.81 KDM4E (0.44) LMNAGAAMAPTTSHRCYP2D6
SCHEMBL868426 0.79 ALDH1A1 (0.47) CA1CA2L3MBTL1MEN1KMT2A
SCHEMBL28903823 0.78 ALDH1A1 (0.44) LMNAGAAMAPTPOLBCYP2D6
SCHEMBL21834507 0.78 CA1 (0.36) HTTCA1CA2L3MBTL1MEN1
SCHEMBL8338879 0.77 ALDH1A1 (0.48) CA1CA2L3MBTL1MEN1KMT2A
SCHEMBL14779616 0.77 EBP (0.43) CA1CA2MEN1KMT2AGAA
SCHEMBL27828517 0.77 CA1 (0.38) CA1CA2MEN1KMT2APKM
SCHEMBL10409064 0.76 CA1 (0.47) HTTCA1CA2L3MBTL1MEN1
SCHEMBL14780195 0.75 EBP (0.41) CA1CA2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130216723-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS KING INDUSTRIES (US) 2013-08-22 US claimed
US-20090104363-A1 Sulfonate esters as latent acid catalysts KING INDUSTRIES 2009-04-23 US claimed
EP-0142805-A2 Aminoplast curable compositions containing disulfonic acid esters as latent acid catalysts PPG INDUSTRIES, INC. (US) 1985-05-29 EP claimed
US-4501854-A FILMS, COATINGS, PAINTS, MOLDINGS, LAMINATES PPG INDUSTRIES, INC. (US) 1985-02-26 US claimed
EP-0142805-A2 Aminoplast curable compositions containing disulfonic acid esters as latent acid catalysts PPG INDUSTRIES, INC. (US) 1985-05-29 EP disclosed
US-4501854-A FILMS, COATINGS, PAINTS, MOLDINGS, LAMINATES PPG INDUSTRIES, INC. (US) 1985-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104363-A1 Sulfonate esters as latent acid catalysts ORAI1, SARAF, NAPA HTT 2758/4885CA1 173/4885CA2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.